Jade Biosciences, Inc. (JBIO) › Capital ExpendituresJade Biosciences, Inc. (JBIO) — Capital ExpendituresAnnual figures by period end, from SEC filings.2021-12-31: $181.0K2022-12-31: $195.0K2023-12-31: $142.0K2025-12-31: $196.0K$196.0K2021-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$196.0K—2026-03-06From 2025-01-012023-12-31$142.0K-27.2%2025-03-27From 2023-01-012022-12-31$195.0K+7.7%2024-03-25From 2022-01-012021-12-31$181.0K—2023-03-29From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)